GridAI Technologies Corp. (GRDX) Stock Analysis & Investment Frameworks
GridAI Technologies Corp. (GRDX) stock analysis on Invetso. Review GridAI Technologies Corp.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
GridAI Technologies Corp. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: GB
GridAI Technologies Corp. Key Financial Metrics
- Market Cap: $30.09M
- Revenue: $36251.00
- ROE: -55.12%
- ROIC: -40.78%
- Dividend Yield: N/A
About GridAI Technologies Corp.
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
GridAI Technologies Corp. Investment Frameworks
Invetso analyzes GridAI Technologies Corp. (GRDX) across the following frameworks:
- GridAI Technologies Corp. 10Y Growth Potential
- GridAI Technologies Corp. Scenario Analysis
- GridAI Technologies Corp. Risks & Opportunities
- GridAI Technologies Corp. Economic Moat
- GridAI Technologies Corp. Business Model
- GridAI Technologies Corp. Management
- GridAI Technologies Corp. SWOT Analysis
- GridAI Technologies Corp. Porter's 5 Forces
- GridAI Technologies Corp. PESTLE Analysis
- GridAI Technologies Corp. ESG Analysis